Lucid Diagnostics Inc.

NASDAQ:LUCD

Medical - Devices

Healthcare
$0.41 +3.80%

+$0.04 today

Market cap
$79.38M
Beta
1.08
P/E (TTM)
-2.3
EPS (TTM)
-$0.44
52W Low $0.90High $1.63

Volume 2.70M

Average 0.84M

LUCD Account Payables

Amounts the company owes suppliers for goods and services received.

Lucid Diagnostics Inc.NASDAQ: LUCD

Account Payables · Q1 FY2026 · quarter ended Mar 2026

Account payables rises 29.9% from a year ago

Account payables stood at $1.08M at the end of Q1 FY2026, up 29.9% from a year earlier and up 11.0% from the prior quarter. Over 3 fiscal years it compounded at -2.8% a year.

Context

  • Account payables amounted to 3.2% of total assets at the end of Q1 FY2026, up 0.6 pp from a year earlier.
  • Account payables increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether account payables keeps rising in the next quarterly balance sheet after a +29.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.08M+11.0% QoQ
Last fiscal yearDec 2025
$970K-21.8% YoY
Year agoMar 2025
$829K+29.9% since
Account Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+29.9%——
1 year-21.8%——
3-year CAGR-2.8%——
5-year CAGR——
10-year CAGR——

Account Payables history

USD · from the balance sheet

Latest · FY2025
970K USD
Year-over-year change
-21.8%
4-year CAGR
-10.2%

Account Payables vs competitors

How LUCD compares with its peers on the latest reported figures

  • LUCD's Mar 2026 account payables of $1.08M is the lowest of the 10 companies compared; the peer median is $4.42M.
  • Its year-over-year change of +29.9% is the 5th highest of 10, against a peer median of +14.1%.
  • Account payables amounts to 3.2% of total assets for LUCD, versus a peer median of 6.6%.
LUCD Competitors Peer median
Account Payables for LUCD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SCLXScilex Holding CompanyMar 2026$101.58M +77.4%+116.9%34.6%
OWLTOwlet, Inc.Mar 2026$11.78M -7.3%-26.7%13.6%
RCELAVITA Medical, Inc.Mar 2026$7.22M -16.8%+44.0%14.0%
RPIDRapid Micro Biosystems, Inc.Mar 2026$4.67M +77.2%-8.6%7.5%
IRDOpus Genetics, Inc.Mar 2026$4.42M +82.0%+45.5%6.6%
AVRAnteris Technologies Global Corp.Mar 2026$3.79M -30.8%+85.9%1.3%
APYXApyx Medical CorporationMar 2026$2.63M +14.1%+4.6%4.2%
SEERSeer, Inc.Mar 2026$2.5M -43.9%+38.7%0.9%
STSSSkyAI, Inc.Mar 2026$1.58M +143.5%+2.8%0.9%
LUCDLucid Diagnostics Inc.Mar 2026$1.08M +29.9%-2.8%3.2%
Peer median (excluding LUCD) $4.42M+14.1%+38.7%6.6%

Competitors are the stored peer set for LUCD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents53.66M22.47M18.9M22.36M34.71M
Short-term Investments00000
Net Receivables200K17K45K405K643K
Inventory493K111K278K341K353K
Other Current Assets001.98M00
Total Current Assets57.3M24.36M22.07M25.15M37.47M
Property, Plant & Equipment (Net)971K3.6M2.64M3.7M2.62M
Goodwill00000
Intangible Assets03.45M1.42M736K315K
Long-term Investments00000
Tax Assets00000
Other Non-current Assets725K1.11M1.13M1.13M47K
Total Non-current Assets1.7M8.15M5.2M5.57M2.98M
Total Assets59M32.51M27.27M30.72M40.45M
Account Payables1.49M1.06M1.15M1.24M970K
Short-term Debt0013.95M18.6M24M
Tax Payables00000
Deferred Revenue00936K00
Other Current Liabilities557K5.53M791K1.35M2.04M
Total Current Liabilities4.26M8.43M29.38M23.52M28.58M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities01.04M199K1.8M927K
Total Liabilities4.26M9.46M29.58M25.32M29.51M
Common Stock35K41K42K63K131K
Retained Earnings(41.9M)(98.08M)(150.74M)(203.77M)(274.34M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity54.74M23.05M(2.31M)5.39M10.94M
Total Debt02M15.26M21.25M25.82M
Net Debt(53.66M)(20.48M)(3.64M)(1.1M)(8.89M)

Lucid Diagnostics Inc.

NASDAQ:LUCD

Intrinsic Alpha fair value

Locked

Current Price

$0.41

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.